{
    "N/R/U": null,
    "Applicant": "Mallinckrodt Pharma IP Trading DAC",
    "BLA Number": "125523",
    "Proprietary Name": "Raplixa",
    "Proper Name": "Fibrin Sealant (Human)",
    "BLA Type": "351(a)",
    "Strength": "0.5G",
    "Dosage Form": "Powder",
    "Route of Administration": "Topical",
    "Product Presentation": "Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "30-Apr-15",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2058",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}